{"api":"v1","generated_at":"2026-10-01T10:19:47.273Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-leibovich-2018-ca8ec2","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-leibovich-2018-ca8ec2/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-leibovich-2018-ca8ec2","canonical_url":"https://api.magentlab.com/api/calc/leibovich_2018","resource":"https://api.magentlab.com/api/calc/leibovich_2018","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Leibovich 2018 histology-specific RCC models after surgery. Required histology clear_cell, papillary, or chromophobe. ccRCC PFS points (2010 TNM): t1a/t1b/t2a 0, t2b 2, t3a-t3c 3, t4 4; nx/n0 0, n1 2; size ≥10 cm 1; grade 1-2 0, 3 1, 4 3; necrosis 2; max 12; risk low 0-2, intermediate 3-5, high ≥6. Papillary and chromophobe return the 2018 three PFS groups (score 0-2). Not SSIGN. Not Leibovich 2003. magent does not stage or read pathology. Not a diagnosis. Not a medical device.","service_name":"magent","declared_category":null,"declared_tags":["leibovich-2018","rcc","kidney","prognosis","calculator"],"route_template":null,"registry_updated":"2026-09-28T13:54:32.357Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc leibovich 2018","category":"inference","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T13:54:32.197Z"},"validation":{"latest":{"observed_at":"2026-10-01T09:23:47.996Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":4,"passed":4,"ratio":1},{"days":30,"observed":4,"passed":4,"ratio":1},{"days":90,"observed":4,"passed":4,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T09:23:47.996Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T08:52:12.743Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:57:16.437Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:48:47.086Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["leibovich-2018","rcc","kidney","prognosis","calculator"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/leibovich_2018","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T13:54:32.197Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/leibovich_2018","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"n_stage":"n0","t_stage":"t1a","necrosis":false,"histology":"clear_cell","nuclear_grade":2,"tumor_size_cm":3},{"n_stage":"n0","t_stage":"t1a","necrosis":false,"histology":"clear_cell","nuclear_grade":2,"tumor_size_cm":3}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/leibovich_2018","count":2,"items":[{"risk":"low","score":0,"formula":"leibovich_2018","n_stage":"n0","t_stage":"t1a","citation":{"id":"leibovich-2018","doi":"10.1016/j.eururo.2018.01.005","pmid":"29398265","title":"Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery","source":"Eur Urol. 2018;73(5):772-780","authors":"Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"},"necrosis":false,"histology":"clear_cell","max_score":12,"components":[{"value":"t1a","factor":"t_stage","points":0,"present":true},{"value":"n0","factor":"n_stage","points":0,"present":true},{"value":3,"factor":"tumor_size_cm","points":0,"present":false},{"value":2,"factor":"nuclear_grade","points":0,"present":true},{"factor":"necrosis","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","nuclear_grade":2,"tumor_size_cm":3,"formula_expression":"ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."},{"risk":"low","score":0,"formula":"leibovich_2018","n_stage":"n0","t_stage":"t1a","citation":{"id":"leibovich-2018","doi":"10.1016/j.eururo.2018.01.005","pmid":"29398265","title":"Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery","source":"Eur Urol. 2018;73(5):772-780","authors":"Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP"},"necrosis":false,"histology":"clear_cell","max_score":12,"components":[{"value":"t1a","factor":"t_stage","points":0,"present":true},{"value":"n0","factor":"n_stage","points":0,"present":true},{"value":3,"factor":"tumor_size_cm","points":0,"present":false},{"value":2,"factor":"nuclear_grade","points":0,"present":true},{"factor":"necrosis","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","nuclear_grade":2,"tumor_size_cm":3,"formula_expression":"ccRCC PFS (Leibovich 2018, 2010 TNM): t_stage (t1a/t1b/t2a 0, t2b 2, t3a/t3b/t3c 3, t4 4) + n_stage (nx/n0 0, n1 2) + tumor_size_cm >=10 1 + nuclear_grade (1-2 0, 3 1, 4 3) + necrosis 2; max 12; risk low 0-2, intermediate 3-5, high >=6. papillary PFS groups: low grade 1-2 and t1-t2; intermediate grade 3 and t1-t2; high grade 4 or t3a-t4 (fat or thrombus). chromophobe PFS groups: low t1-t2 and nx/n0; intermediate t3a-t4 and nx/n0 (fat); high n1. Not Frank 2002 SSIGN. Not Leibovich 2003. No chromophobe CSS model."}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["histology","t_stage","n_stage","tumor_size_cm","nuclear_grade","necrosis"],"properties":{"n_stage":{"enum":["nx","n0","n1"],"type":"string","description":"2010 pathologic N as assigned by the caller (Leibovich 2018). nx or n0 scores 0 on ccRCC; n1 scores 2. Not n2 (2002 N). magent does not stage nodes."},"t_stage":{"enum":["t1a","t1b","t2a","t2b","t3a","t3b","t3c","t4"],"type":"string","description":"2010 pathologic T as assigned by the caller (Leibovich 2018). t1a, t1b, t2a, t2b, t3a, t3b, t3c, or t4. Not 1997/2002 T without a/b substages. magent does not stage the tumor."},"necrosis":{"type":"boolean","description":"Histologic tumor necrosis as assigned by the caller (Leibovich 2018). true scores 2 on ccRCC. magent does not read slides."},"histology":{"enum":["clear_cell","papillary","chromophobe"],"type":"string","description":"Surgical histology as assigned by the caller (Leibovich 2018). clear_cell, papillary, or chromophobe. Not collecting-duct or unclassified. magent does not read slides."},"nuclear_grade":{"type":"integer","description":"Nuclear grade 1-4 as assigned by the caller (Leibovich 2018). On ccRCC, 1-2 score 0; 3 scores 1; 4 scores 3. Integer 1-4 only; reject 0, 5, 1.5, and roman I. magent does not read slides."},"tumor_size_cm":{"type":"number","description":"Maximum tumor size in cm as assigned by the caller (Leibovich 2018). Unrounded; 10.0 cm or greater scores 1 on ccRCC. Magent clamp 0.1-30, not a published range. magent does not measure the tumor."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Leibovich 2018 histology-specific RCC models after surgery. Required histology clear_cell, papillary, or chromophobe. ccRCC PFS points (2010 TNM): t1a/t1b/t2a 0, t2b 2, t3a-t3c 3, t4 4; nx/n0 0, n1 2; size ≥10 cm 1; grade 1-2 0, 3 1, 4 3; necrosis 2; max 12; risk low 0-2, intermediate 3-5, high ≥6. Papillary and chromophobe return the 2018 three PFS groups (score 0-2). Not SSIGN. Not Leibovich 2003. magent does not stage or read pathology. Not a diagnosis. Not a medical device.","lastUpdated":"2026-09-28T13:54:32.357Z","serviceName":"magent","x402Version":2}]}}